Portal de Oportunidades de Pesquisa – POP Pró-Reitoria de Pesquisa

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The aim is to fund ambitious transnational RTD projects addressing materials research and innovation including materials for low carbon energy technologies and related production technologies. M-ERA.NET aims to strengthen the contribution of materials R&D to energy-related applications where applicable.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases.  For this RFP, studies related to PMP and appendix cancer as a disease of origin for PMP will be considered.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: Perhaps nowhere else in dermatology is so little known about a disorder that affects so many. Because the cause of rosacea is unknown and there is no cure, the National Rosacea Society’s research grants program was established in 1999 to encourage and support research into the potential causes and other key aspects of this condition that may lead to improvements in its treatment and potential prevention or cure.

Inscrições: até 17 de junho de 2019

Mais informações no site.